Kwinta, Ł.; Konopka, K.; Okoń, K.; Łobacz, M.; Chłosta, P.; Dudek, P.; Buda-Nowak, A.; Potocki, P.; Wysocki, P.J.
Neoadjuvant Accelerated Methotrexate, Vinblastine, Doxorubicin, and Cisplatin Chemotherapy for Muscle-Invasive Urothelial Cancer: Large, Single-Center Analysis of Consecutive Patients’ Data. Cancers 2025, 17, 258.
https://doi.org/10.3390/cancers17020258
AMA Style
Kwinta Ł, Konopka K, Okoń K, Łobacz M, Chłosta P, Dudek P, Buda-Nowak A, Potocki P, Wysocki PJ.
Neoadjuvant Accelerated Methotrexate, Vinblastine, Doxorubicin, and Cisplatin Chemotherapy for Muscle-Invasive Urothelial Cancer: Large, Single-Center Analysis of Consecutive Patients’ Data. Cancers. 2025; 17(2):258.
https://doi.org/10.3390/cancers17020258
Chicago/Turabian Style
Kwinta, Łukasz, Kamil Konopka, Krzysztof Okoń, Mateusz Łobacz, Piotr Chłosta, Przemysław Dudek, Anna Buda-Nowak, Paweł Potocki, and Piotr J. Wysocki.
2025. "Neoadjuvant Accelerated Methotrexate, Vinblastine, Doxorubicin, and Cisplatin Chemotherapy for Muscle-Invasive Urothelial Cancer: Large, Single-Center Analysis of Consecutive Patients’ Data" Cancers 17, no. 2: 258.
https://doi.org/10.3390/cancers17020258
APA Style
Kwinta, Ł., Konopka, K., Okoń, K., Łobacz, M., Chłosta, P., Dudek, P., Buda-Nowak, A., Potocki, P., & Wysocki, P. J.
(2025). Neoadjuvant Accelerated Methotrexate, Vinblastine, Doxorubicin, and Cisplatin Chemotherapy for Muscle-Invasive Urothelial Cancer: Large, Single-Center Analysis of Consecutive Patients’ Data. Cancers, 17(2), 258.
https://doi.org/10.3390/cancers17020258
